DC
GILD icon

Defender Capital’s Gilead Sciences GILD Stock Holding History

Defender Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$224K Buy
+1,500
New +$210K 0.07% 36
2026
Q2 		– Sell
-1,500
Closed -$209K – 40
2026
Q1 		$209K Buy
+1,500
New +$210K 0.07% 32

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Defender Capital's GILD Position: Q3 2026 in Review

Defender Capital opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,500 shares worth $224K. The stake represents 0.07% of the portfolio and ranks #36 among its holdings. This is a return to the name: Defender Capital previously reported a position in GILD as recently as Q1 2026.

Defender Capital first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Defender Capital held 1,500 shares of Gilead Sciences worth $224K as of Q3 2026.
  • Gilead Sciences was a new Defender Capital position in Q3 2026.
  • Gilead Sciences made up 0.07% of Defender Capital's portfolio in Q3 2026, its #36 holding.
  • Defender Capital first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Defender Capital's 13F filing for Q3 2026, filed 1 Oct 2026.